2- chloro- 4- (3- (6,7- dimethoxy- 2- methyl- 1- (3,4,5- trimethoxyphenyl)- 1,2,3,4- tetrahydro- 2- isoquinolinio)propyl)- 1- (3- (2- methyl- 6,7- dimethoxy- 1- ((3,4,5- trimethoxyphenyl)methyl)- 1,2,3,4- teterahydro- 2- isoquinolinio)propyl)- 2- butenedioate
a neuromuscular blocker; structure in first source
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
- Organic Chemicals: 133
- Hydrocarbons: 1713
- Cyclic Hydrocarbons: 97
- Aromatic Hydrocarbons: 291
- Benzene Derivatives: 17
- Phenols: 677
- Phenyl Ethers: 8
- Anisoles
- 2-chloro-4-(3-(6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydro-2-isoquinolinio)propyl)-1-(3-(2-methyl-6,7-dimethoxy-1-((3,4,5-trimethoxyphenyl)methyl)-1,2,3,4-teterahydro-2-isoquinolinio)propyl)-2-butenedioate
- Ethers: 242
- Methyl Ethers: 19
- Anisoles
- 2-chloro-4-(3-(6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydro-2-isoquinolinio)propyl)-1-(3-(2-methyl-6,7-dimethoxy-1-((3,4,5-trimethoxyphenyl)methyl)-1,2,3,4-teterahydro-2-isoquinolinio)propyl)-2-butenedioate
- Phenyl Ethers: 8
- Anisoles
- 2-chloro-4-(3-(6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydro-2-isoquinolinio)propyl)-1-(3-(2-methyl-6,7-dimethoxy-1-((3,4,5-trimethoxyphenyl)methyl)-1,2,3,4-teterahydro-2-isoquinolinio)propyl)-2-butenedioate
- Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
- 2-Ring Heterocyclic Compounds
- Isoquinolines: 34
- 2-chloro-4-(3-(6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydro-2-isoquinolinio)propyl)-1-(3-(2-methyl-6,7-dimethoxy-1-((3,4,5-trimethoxyphenyl)methyl)-1,2,3,4-teterahydro-2-isoquinolinio)propyl)-2-butenedioate